Bridge to Life to Present Novel Research at the 2026 ILTS Congress in Geneva
Bridge to Life to Present at the 2026 ILTS Congress
Bridge to Life™ Ltd, a prominent global player in organ preservation solutions and perfusion technology, has announced its participation in the 2026 International Congress of the International Liver Transplantation Society (ILTS). The event will unfold from May 6 to May 9, 2026, in the vibrant city of Geneva, Switzerland. This prestigious conference gathers experts and innovators in liver transplantation from around the globe, making it a pivotal platform for presenting groundbreaking research.
Overview of Presentations
This year, Bridge to Life will present a total of 12 abstracts that have been accepted for presentation, which includes five oral presentations—one of which will be part of a plenary session—and seven poster presentations. The topics revolve around advanced methodologies in hypothermic oxygenated perfusion (HOPE), a technique that enhances the viability of liver transplants.
Highlights from Oral Presentations
Among the key highlights, the oral presentations feature prominent research findings, including:
1. **
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.